LENALIDOMID ZENTIVA 25MG Tvrdá tobolka チェコ共和国 - チェコ語 - SUKL (Státní ústav pro kontrolu léčiv)

lenalidomid zentiva 25mg tvrdá tobolka

zentiva, k.s., praha array - 17180 lenalidomid - tvrdá tobolka - 25mg - lenalidomid

LENALIDOMID ZENTIVA 5MG Tvrdá tobolka チェコ共和国 - チェコ語 - SUKL (Státní ústav pro kontrolu léčiv)

lenalidomid zentiva 5mg tvrdá tobolka

zentiva, k.s., praha array - 17180 lenalidomid - tvrdá tobolka - 5mg - lenalidomid

Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) 欧州連合 - チェコ語 - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresiva - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikován k léčbě dospělých pacientů s dříve neléčeným mnohočetným myelomem, kteří nejsou způsobilí pro transplantaci. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 a 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikován k léčbě dospělých pacientů s dříve neléčeným mnohočetným myelomem, kteří nejsou způsobilí pro transplantaci. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 a 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Teriflunomide Mylan 欧州連合 - チェコ語 - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord 欧州連合 - チェコ語 - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva, selektivní imunosupresiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Lenalidomide Accord 欧州連合 - チェコ語 - EMA (European Medicines Agency)

lenalidomide accord

accord healthcare s.l.u. - lenalidomid - mnohočetný myelom - imunosupresiva - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikován k léčbě dospělých pacientů s dříve neléčeným mnohočetným myelomem, kteří nejsou způsobilí pro transplantaci. lenalidomid accord v kombinaci s dexamethasonem je indikován k léčbě mnohočetného myelomu u dospělých pacientů, kteří absolvovali alespoň jednu předchozí terapii. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

LENALIDOMIDE GLENMARK 10MG Tvrdá tobolka チェコ共和国 - チェコ語 - SUKL (Státní ústav pro kontrolu léčiv)

lenalidomide glenmark 10mg tvrdá tobolka

glenmark pharmaceuticals s.r.o., praha array - 17180 lenalidomid - tvrdá tobolka - 10mg - lenalidomid

LENALIDOMIDE GLENMARK 15MG Tvrdá tobolka チェコ共和国 - チェコ語 - SUKL (Státní ústav pro kontrolu léčiv)

lenalidomide glenmark 15mg tvrdá tobolka

glenmark pharmaceuticals s.r.o., praha array - 17180 lenalidomid - tvrdá tobolka - 15mg - lenalidomid

LENALIDOMIDE GLENMARK 25MG Tvrdá tobolka チェコ共和国 - チェコ語 - SUKL (Státní ústav pro kontrolu léčiv)

lenalidomide glenmark 25mg tvrdá tobolka

glenmark pharmaceuticals s.r.o., praha array - 17180 lenalidomid - tvrdá tobolka - 25mg - lenalidomid

LENALIDOMIDE GLENMARK 5MG Tvrdá tobolka チェコ共和国 - チェコ語 - SUKL (Státní ústav pro kontrolu léčiv)

lenalidomide glenmark 5mg tvrdá tobolka

glenmark pharmaceuticals s.r.o., praha array - 17180 lenalidomid - tvrdá tobolka - 5mg - lenalidomid